kezar life sciences stock news

KZR stock quote history news and other vital information to help you with your stock trading and investing. NASDAQKZR Get Rating will report earnings per share EPS of 031.

Kezar Life Sciences Key Catalysts Ahead Nasdaq Kzr Seeking Alpha

The stock option will vest over a four-year period with 25 of the option vesting on the first anniversary.

. Kezar Life Sciences Inc. KZR shares are trading lower by 3823 at 761 after the company announced top-line results from its PRESIDIO Phase 2 clinical trial of Zetomipzomib. Ad Search Ex-Dividend Dates Dividend Calendar All-Star Rankings More.

Wall Street brokerages predict that Kezar Life Sciences Inc. NASDAQKZR fell 39 to 751 after the company reported topline results from the PRESIDIO Phase 2 trial of zetomipzomib KZR-616 in patients with dermatomyositis DM. KZR a clinical-stage biotechnology.

SOUTH SAN FRANCISCO Calif. Stock screener for investors and traders financial visualizations. Find the latest Kezar Life Sciences Inc.

BUSINESS WIRE May 3 2022 Kezar Life Sciences Inc Nasdaq. SOUTH SAN FRANCISCO Calif--BUSINESS WIRE--Kezar Life Sciences Inc Nasdaq. Kezar Life Sciences Inc NASDAQ.

Kezar Life Sciences Shares Surge. 2 days agoA number of analysts recently commented on the stock. Crude Oil Down 1.

HC Wainwright upped their price objective on shares of Kezar Life Sciences from 2000 to 2200 and gave the company a buy rating in a. Why On Holding Stock Ran Nearly 21 Higher Today.

Kezar Life Sciences Inc Kzr May Find A Bottom Soon Here S Why You Should Buy The Stock Now Nasdaq